Endothelial Dysfunction and COVID-19
Endothelial dysfunction is a cardiac condition that is the precursor of atherosclerosis. It is controlled by the so called "cardiovascular risk factors", and when these risk factors are treated, this condition can be reversed. Endothelial dysfunction leads to:
- plaque buildup in vascular tissue
- thrombosis
- vasoconstriction
- inflammation
- oxidative stress
- vascular tissue remodeling
Endothelial dysfunction is a comorbidity of conditions that have been shown to aggravate a SARS-CoV-2, including obesity. It also causes phenomena that might mechanistically enhance COVID-19.
0
1
Contributors are:
Who are from:
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Disability Studies
Social Science
Empirical Science
Science
Related
Cardiovascular Manifestations of COVID-19 (graphic)
COVID-19 and Cardiac Arrhythmia (irregular heart rhythm)
COVID-19 and Myocarditis
Endothelial Dysfunction and COVID-19
Mechanism for direct myocardial injury in COVID-19 patients
Aortic Thrombosis and COVID-19
Predisposing Factors for Thrombotic Disease in COVID-19